# Effect of Aspirin Pretreatment or Slow Dose Titration on Flushing and Gastrointestinal Events in Healthy Volunteers Receiving Delayed-release Dimethyl Fumarate

> **NCT01568112** · PHASE3 · COMPLETED · sponsor: **Biogen** · enrollment: 173 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BG00012 (dimethyl fumarate)
- **DRUG:** BG00012 placebo
- **DRUG:** ASA
- **DRUG:** ASA placebo

## Key facts

- **NCT ID:** NCT01568112
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 173 (ACTUAL)
- **Last updated:** 2016-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01568112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01568112, "Effect of Aspirin Pretreatment or Slow Dose Titration on Flushing and Gastrointestinal Events in Healthy Volunteers Receiving Delayed-release Dimethyl Fumarate". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01568112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*